Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative magnesium sulphate for prevention of postoperative cognitive dysfunction
PACTR201810909649406Not yet recruiting
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of magnesium sulfate in post-operative cognitive decline (POCD) (2 arms). Primary endpoint: cognitive dysfunction. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on PACTR201810909649406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810909649406.